PDS Biotechnology (PDSB) AGM 2026 summary

Opening remarks and agenda

• Welcomed stockholders to the 2026 virtual annual meeting, enabling participation and voting online.

• Outlined the meeting agenda: election of two Class B directors, amendment to the certificate of incorporation, ratification of KPMG LLP as auditor, and advisory vote on executive compensation.

• Introduced board members, senior management, and external advisors present at the meeting.

Corporate governance

• Described voting procedures, eligibility, and the role of the Inspector of Voting.

• Confirmed a quorum was present, allowing business to proceed.

• Provided access to proxy materials and a certified list of stockholders.

Overview of voting outcomes

• All nominees for Class B director positions were elected for three-year terms.

• Amendment to the certificate of incorporation was approved.

• KPMG LLP's appointment as independent auditor for 2026 was ratified.

• Executive compensation was approved by a non-binding advisory vote.

• Final voting results to be filed with the SEC within four business days.